Analystreport

PDS Biotechnology Co. (NASDAQ: PDSB) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.

PDS Biotechnology Corporation  (PDSB) 
Last pds biotechnology corporation earnings: 11/7 06:00 am Check Earnings Report